Open access
92
Views
5
CrossRef citations to date
0
Altmetric
Original Research
The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports
David G Perahia1 Neurosciences, Lilly Research Centre, Windlesham, Surrey, UKCorrespondence[email protected]
, Mark E Bangs2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
, Qi Zhang2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
, Yingkai Cheng2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
, Jonna Ahl2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
, Elijah P Frakes2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
, Michael J Adams2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
& James M Martinez2 Neurosciences, Eli Lilly and Company, Indianapolis, IN, USA
show all
Pages 211-219
|
Published online: 25 Nov 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.